Angina Pectoris: Clinical Trials

15 trials for Angina Pectoris, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 terminated. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Terminated 15

Follow Angina Pectoris: new trials by email Literature Review of Angina Pectoris trials Research Report on Angina Pectoris

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention
Prasugrel, Clopidogrel - Angina Pectoris
Phase 4TerminatedLMU Klinikum7952015-09-012020-07-17
ANti-Oxidant in Variant Angina (ANOVA) Trial
Vitamin C and Vitamin E, Statin, Standard medication for variant angina - Variant Angina
Phase 4TerminatedSeoul National University Hospital3202014-09-012026-04-27
Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD
ramipril, rosuvastatin, placebo - Coronary Artery Dissection, Spontaneous
Phase 4TerminatedCardiology Research UBC182014-06-012024-03-15
Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome
Ticagrelor, Clopidogrel - Acute Coronary Syndrome, Acute Myocardial Infarction
Phase 4TerminatedYonsei University1482014-01-012019-03-29
Routine Versus Selective Use of FFR to Guide PCI
Fractional Flow Reserve (FFR) - Acute Coronary Syndrome, Coronary Atherosclerosis
Phase 4TerminatedCardiology Research UBC2612014-01-012019-02-26
Allopurinol in Acute Coronary Syndrome
Allopurinol, Placebo - Chronic Stable Angina
Phase 4TerminatedStephen McSwiggan262012-04-012015-05-27
Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy
Endothelial cell capture stent with 1 month clopidogrel, Everolimus eluting stent with 12 month clopidogrel, Atorvastatin 20mg loading - Stable Angina
Phase 4TerminatedYonsei University12011-10-012013-12-04
The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study
drug eluting balloon, drug eluting stent - Stable Angina, Coronary Stenosis
Phase 4TerminatedAalborg University Hospital2011-05-012014-03-18
Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol
Esmolol, Metoprolol - Vascular Disease, Hypertension
Phase 4TerminatedUniversity Health Network, Toronto202011-04-012015-04-21
Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention
Bivalirudin, Heparin - Coronary Artery Disease
Phase 4TerminatedStony Brook University2602009-07-012014-11-20
A COMparison Between PAClitaxel-coated Balloon and pacliTaxel-eluting Stent in the Treatment of In-Stent Restenosis (COMPACT-ISR)
Paclitaxel-coated Balloon, Paclitaxel-eluting Stent - Stable Angina, Unstable Angina
Phase 4TerminatedOspedale San Donato1542008-01-012010-09-17
Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)
enoxaparin - Unstable Angina
Phase 4TerminatedCanadian Heart Research Centre112007-08-012016-01-27
Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome
Dalteparin ( Fragmin), Unfractionated heparin - Angina, Unstable, Myocardial Infarction
Phase 4TerminatedPfizer1732007-06-012011-10-17
Rosiglitazone Versus Placebo in Chronic Stable Angina
Rosiglitazone - Angina Pectoris, Metabolic Syndrome X
Phase 4TerminatedUniversity of Glasgow802006-02-012009-02-19
Comparison of SCS and PMR in Patients With Refractory Angina Pectoris
Spinal Cord Stimulation (SCS), Percutaneous Myocardial Laser Revascularisation (PMR) - Angina Pectoris
Phase 4TerminatedMedtronic662000-09-012005-12-16

Narrower conditions

Angina, Stable (5)  ·  Angina, Unstable (5)  ·  Acute Coronary Syndrome (3)  ·  Coronary Artery Disease (3)  ·  Myocardial Infarction (2)  ·  Angina Pectoris, Variant (1)  ·  Coronary Artery Dissection, Spontaneous (1)  ·  Coronary Stenosis (1)  ·  Heart Diseases (1)  ·  Hemorrhage (1)  ·  Hypertension (1)  ·  Metabolic Syndrome (1)  ·  Myocardial Ischemia (1)  ·  Vascular Diseases (1)

Broader conditions

Cardiovascular Diseases (15)  ·  Chest Pain (15)  ·  Neurologic Manifestations (15)  ·  Pain (15)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Signs and Symptoms (15)  ·  Heart Diseases (14)  ·  Myocardial Ischemia (14)  ·  Vascular Diseases (14)  ·  Coronary Disease (4)  ·  Arterial Occlusive Diseases (3)  ·  Arteriosclerosis (3)  ·  Infarction (2)  ·  Ischemia (2)

Interventions

Atorvastatin (2)  ·  Clopidogrel (2)  ·  Heparin (2)  ·  Allopurinol (1)  ·  Ascorbic Acid (1)  ·  Calcium Channel Blockers (1)  ·  Dalteparin (1)  ·  Drug-Eluting Stents (1)  ·  Enoxaparin (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  Metoprolol (1)  ·  Prasugrel Hydrochloride (1)  ·  Ramipril (1)  ·  Rosiglitazone (1)  ·  Rosuvastatin Calcium (1)

Sponsors

Cardiology Research UBC (2)  ·  Yonsei University (2)  ·  Aalborg University Hospital (1)  ·  Canadian Heart Research Centre (1)  ·  LMU Klinikum (1)  ·  Medtronic (1)  ·  Ospedale San Donato (1)  ·  Pfizer (1)  ·  Seoul National University Hospital (1)  ·  Stephen McSwiggan (1)  ·  Stony Brook University (1)  ·  University Health Network, Toronto (1)  ·  University of Glasgow (1)

Countries

Canada (4)  ·  South Korea (3)  ·  United Kingdom (3)  ·  Denmark (1)  ·  Germany (1)  ·  Hungary (1)  ·  India (1)  ·  Italy (1)  ·  United States (1)

Top investigators

Allan Struthers, BSc, MD, FRCP, FRSE, FMedSci (1)  ·  Allen Jeremias, MD (1)  ·  Anatoly Langer, MD, MSc (1)  ·  Andrew T Yan, MD (1)  ·  Anthony Fung, MBBS, FRCPC (1)  ·  David Fitchett, MD (1)  ·  Hyo-Soo Kim, Kim (1)  ·  Julinda Mehilli, MD (1)  ·  Leonardo Bolognese, MD (1)  ·  Naveed Sattar, MBChB PhD (1)  ·  Peter Schofield, MD (1)  ·  Scott Beattie, MD, FRCP (1)  ·  Seung-Hwan Lee, MD, PhD (1)  ·  Shaun Goodman, MD, MSc (1)

Results publications

PMID 32527192